Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.

MLA

Gupta, Ajay, et al. “Legacy Benefits of Blood Pressure Treatment on Cardiovascular Events Are Primarily Mediated by Improved Blood Pressure Variability: The ASCOT Trial.” European Heart Journal, vol. 45, no. 13, Apr. 2024, pp. 1159–69. EBSCOhost, https://doi.org/10.1093/eurheartj/ehad814.

APA

Gupta, A., Whiteley, W. N., Godec, T., Rostamian, S., Ariti, C., Mackay, J., Whitehouse, A., Janani, L., Poulter, N. R., Sever, P. S., & Investigators, the A.-10. (2024). Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial. European Heart Journal, 45(13), 1159–1169. https://doi.org/10.1093/eurheartj/ehad814

Chicago

Gupta, Ajay, William N Whiteley, Thomas Godec, Somayeh Rostamian, Cono Ariti, Judith Mackay, Andrew Whitehouse, et al. 2024. “Legacy Benefits of Blood Pressure Treatment on Cardiovascular Events Are Primarily Mediated by Improved Blood Pressure Variability: The ASCOT Trial.” European Heart Journal 45 (13): 1159–69. doi:10.1093/eurheartj/ehad814.